SCI Pharmtech, Inc.
4119
Rank in Stocks
#17180
SCI Pharmtech, Inc., founded in 1987 and based in Taoyuan City, Taiwan,... SCI Pharmtech, Inc., founded in 1987 and based in Taoyuan City, Taiwan, specializes in the comprehensive lifecycle of pharmaceutical components. The company's core operations involve the research and development, manufacturing, and global distribution of active pharmaceutical ingredients (APIs), chemical intermediates, and specialty chemicals. Its extensive portfolio of APIs includes critical compounds such as Articaine HCl, Atomoxetine HCl, Bisoprolol Fumarate, Brinzolamide, Cannabidiol, and Dexmethylphenidate HCl, among many others. Additionally, SCI Pharmtech produces a wide array of intermediate products, featuring substances like Azetidin-3-ol hydrogenchloride, Diethyl Isobutyl Malonate, Pyrogallolaldehyde, and various specialized esters and alcohols, which serve as essential building blocks in chemical synthesis. Beyond its standard product lines, the company also offers custom manufacturing services tailored to specific client needs. SCI Pharmtech maintains a robust international presence, distributing its products to significant markets across the globe, including Italy, China, the United States, Germany, Taiwan, Switzerland, Spain, Japan, and the Netherlands.
Share Price
$1.49
Last synced: 2026-11-10
Market Cap
$178.33M
Change (1 day)
-3.64%
Change (1 year)
-8.89%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade SCI Pharmtech, Inc. (4119)
Category
Healthcare
EPS for SCI Pharmtech, Inc. (4119)
EPS as of June 2026 TTM: $0.02
According to SCI Pharmtech, Inc.'s latest financial reports, its current EPS (TTM) is $0.02. At the end of 2025 the company had an EPS of $0.03, a decrease compared to its 2024 EPS of $0.14.
EPS history for SCI Pharmtech, Inc. from 2009 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.02 | -47.67% |
| 2025 | $0.03 | -78.93% |
| 2024 | $0.14 | 54.77% |
| 2023 | $0.09 | -4.66% |
| 2022 | $0.09 | 401.63% |
| 2021 | $0.02 | -84.34% |
| 2020 | $0.12 | -32.93% |
| 2019 | $0.18 | 28.45% |
| 2018 | $0.14 | 125.83% |
| 2017 | $0.06 | -50.53% |
| 2016 | $0.12 | 4.90% |
| 2015 | $0.12 | 29.91% |
| 2014 | $0.09 | 55.56% |
| 2013 | $0.06 | -35.14% |
| 2012 | $0.09 | 131.85% |
| 2011 | $0.04 | -49.93% |
| 2010 | $0.08 | 11.19% |
| 2009 | $0.07 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 41,310.19% |
DE
|
|
| $6.08 | 38,610.83% |
DE
|
|
| $1.55 | 9,776.43% |
JP
|
|
| $3.66 | 23,212.10% |
CH
|
|
| $0.45 | 2,766.24% |
IL
|
Questions about SCI Pharmtech, Inc.'s earnings per share (EPS)
What is SCI Pharmtech, Inc.'s earnings per share (EPS)?
SCI Pharmtech, Inc.'s earnings per share (EPS) over the last twelve months is $0.02, as of Jun 2026.
What was SCI Pharmtech, Inc.'s earnings per share (EPS) in 2025?
In 2025, SCI Pharmtech, Inc.'s earnings per share (EPS) was $0.03, 78.57% less than in 2024 ($0.14).
How has SCI Pharmtech, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, SCI Pharmtech, Inc.'s earnings per share (EPS) went from $0.12 to $0.03, an average decline of 24.21% a year.
How does SCI Pharmtech, Inc.'s earnings per share (EPS) compare with similar companies?
SCI Pharmtech, Inc.'s earnings per share (EPS) ($0.02) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.